Condition: Respiratory Tract Infections · Wheezing Lower Respiratory Illness · Sponsor: OM Pharma SA
This study will assess the efficacy and safety of OM-85 compared to placebo in reducing the number of respiratory tract infections (RTIs) in children aged between 6 months and 5 years.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| Ludwig Maximilians Universität München | München, Bavaria, Germany | — |
| Clinical Research & Healthcare GmbH | Schönau am Königssee, Bavaria, Germany | — |
| Medizinische Hochschule Hannover | Hanover, Lower Saxony, Germany | — |
| St. Josef-Hospital | Bochum, North Rhine-Westphalia, Germany | — |
| University Hospital Cologne AöR | Cologne, North Rhine-Westphalia, Germany | — |
| Ev. Krankenhaus Düsseldorf | Düsseldorf, North Rhine-Westphalia, Germany | — |
| Praxis Köllges | Mönchengladbach, North Rhine-Westphalia, Germany | — |
| Marien-Hospital Wesel gGmbH | Wesel, North Rhine-Westphalia, Germany | — |
| Universitätsklinikum Schleswig-Holstein Campus Lübeck | Lübeck, Schleswig-Holstein, Germany | — |
| Aranyklinika Kft | Szeged, Csongrád megye, Hungary | — |
| Dr. Kenessey Albert Korhaz-Rendelointezet | Balassagyarmat, Hungary | — |
| Semmelweis Egyetem I.sz. Gyermekgyogyaszati Klinika | Budapest, Hungary | — |
+ 30 more locations — full list on the registry record.
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.